Neurochemical and behavioral characteristics of toxic milk mice: An animal model of wilson's disease

Neurochemical Research

Volumn 38, Issue 10, 2013, Pages 2037-2045

  Przybyłkowski, Adam ^a,b   Gromadzka, Grazyna ^a,c   Wawer, Adriana ^a   Bulska, Ewa ^d   Jabłonka Salach, Katarzyna ^d   Grygorowicz, Tomasz ^a   Schnejder Pachołek, Anna ^a   Członkowski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Endoterapia ^*  (Poland)

^c INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^d UNIVERSITY OF WARSAW   (Poland)

Author keywords

Neuropathology; Toxic milk mice; Wilson's disease

Indexed keywords

BRAIN MONOAMINE; CERULOPLASMIN; COPPER; DOPAMINE; DOPAMINE BETA MONOOXYGENASE; IRON; SEROTONIN; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE; ZINC;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN LEVEL; BRAIN REGION; CERULOPLASMIN BLOOD LEVEL; CONTROLLED STUDY; COORDINATION DISORDER; COPPER BRAIN LEVEL; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; EXPERIMENTAL MOUSE; EXPERIMENTAL TEST; FEMALE; GAIT DISORDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IRON BRAIN LEVEL; LIVER EXAMINATION; LIVER WEIGHT; MALE; MOTOR DYSFUNCTION; MOUSE; NEUROCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; ROTAROD TEST; SEROTONIN BRAIN LEVEL; SEROTONINERGIC NERVE CELL; SPLEEN WEIGHT; TOXIC MILK MOUSE; WILSON DISEASE; ZINC BRAIN LEVEL;

ANIMALIA; MUS; RODENTIA;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BRAIN CHEMISTRY; CATION TRANSPORT PROTEINS; DISEASE MODELS, ANIMAL; DOPAMINE BETA-HYDROXYLASE; FEMALE; HEPATOLENTICULAR DEGENERATION; MALE; MICE; MILK; MOTOR ACTIVITY; ROTAROD PERFORMANCE TEST; TRYPTOPHAN HYDROXYLASE; TYROSINE 3-MONOOXYGENASE;

EID: 84884910690     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1111-3     Document Type: Article

References (32)

1. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML (2007) Wilson's disease. Lancet 369(9559):397-408. doi: 10.1016/S0140-6736(07)60196-2
2. Fuentealba IC, Aburto EM (2003) Animal models of copper-associated liver disease. Comp Hepatol 2(1):5
3. Rauch H (1983) Toxic milk, a new mutation affecting cooper metabolism in the mouse. J Hered 74(3):141-144
4. Coronado V, Nanji M, Cox DW (2001) The Jackson toxic milk mouse as a model for copper loading. Mamm Genome 12(10):793-795
5. Roberts EA, Robinson BH, Yang S (2008) Mitochondrial structure and function in the untreated Jackson toxic milk (tx-j) mouse, a model for Wilson disease. Mol Genet Metab 93(1):54-65. doi: 10.1016/j.ymgme.2007.08.127
6. Roberts EA, Lee YS, Wanless IR (2004) Wilsonian liver disease in the Jackson Laboratory toxic milk (tx-j) mouse (abstr.). Clin Biochem 36:1
7. Terwel D, Loschmann YN, Schmidt HH, Scholer HR, Cantz T, Heneka MT (2011) Neuroinflammatory and behavioural changes in the Atp7B mutant mouse model of Wilson's disease. J Neurochem 118(1):105-112. doi: 10.1111/j.1471-4159.2011. 07278.x
8. Gitlin JD (2003) Wilson disease. Gastroenterology 125(6):1868-1877
9. Meenakshi-Sundaram S, Mahadevan A, Taly AB, Arunodaya GR, Swamy HS, Shankar SK (2008) Wilson's disease: a clinico-neuropathological autopsy study. J Clin Neurosci 15(4):409-417. doi: 10.1016/j.jocn.2006.07.017
10. Davidson DL, Yates CM, Mawdsley C, Pullar IA, Wilson H (1977) CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders. J Neurol Neurosurg Psychiatry 40(12):1136-1141
11. Milewska D (1979) Measurment of metabolites of catecholamines in cerebrospinal fluid in paients with Parkinson's disease, Huntington's disease and Wilson's disease. Doctoral thesis, Institute of Psychiatry and Neurology, Warsaw
12. Bronson RTSH, Davisson MT (1995) Acute cerebral neuronal necrosis in copper deficient offspring of female mice with the toxic milk mutation. Mouse Genome 93(1):152-154
13. Ravin HA (1961) An improved colorimetric enzymatic assay of ceruloplasmin. J Lab Clin Med 58:161-168
14. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
15. Bonilla E, Salazar E, Villasmil JJ, Villalobos R, Gonzalez M, Davila JO (1984) Copper distribution in the normal human brain. Neurochem Res 9(11):1543-1548
16. Davies KM, Hare DJ, Cottam V, Chen N, Hilgers L, Halliday G, Mercer JF, Double KL (2012) Localization of copper and copper transporters in the human brain. Metallomics. doi: 10.1039/c2mt20151h
17. Ono S, Koropatnick DJ, Cherian MG (1997) Regional brain distribution of metallothionein, zinc and copper in toxic milk mutant and transgenic mice. Toxicology 124(1):1-10
18. Ahn TB, Cho SS, Kim DW, Jeon BS (2005) Absence of nigrostriatal degeneration in LEC rats up to 20 weeks of age. Neurol Res 27(4):409-411. doi: 10.1179/016164105X48851
19. 123I]ss-CIT and high-resolution SPET. Eur J Nucl Med 28(11):1656-1663. doi: 10.1007/s002590100623
20. Hermann W, Barthel H, Hesse S, Grahmann F, Kuhn HJ, Wagner A, Villmann T (2002) Comparison of clinical types of Wilson's disease and glucose metabolism in extrapyramidal motor brain regions. J Neurol 249(7):896-901. doi: 10.1007/s00415-002-0756-7
21. Samuele A, Mangiagalli A, Armentero MT, Fancellu R, Bazzini E, Vairetti M, Ferrigno A, Richelmi P, Nappi G, Blandini F (2005) Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease. Biochim Biophys Acta 1741(3):325-330. doi: 10.1016/j.bbadis.2005.06.004
22. Kim JM, Ko SB, Kwon SJ, Kim HJ, Han MK, Kim DW, Cho SS, Jeon BS (2005) Ferrous and ferric iron accumulates in the brain of aged Long-Evans Cinnamon rats, an animal model of Wilson's disease. Neurosci Lett 382(1-2):143-147. doi: 10.1016/j.neulet.2005.03.003
23. Kawano H, Takeuchi Y, Yoshimoto K, Matsumoto K, Sugimoto T (2001) Histological changes in monoaminergic neurons of Long-Evans Cinnamon rats. Brain Res 915(1):25-31
24. Porter CC, Titus DC, Sanders BE, Smith EV (1957) Oxidation of serotonin in the presence of ceruloplasmin. Science 126(3281):1014-1015
25. Warner RR, Sternlieb I (1966) Study of a possible physiologic interaction between ceruloplasmin and serotonin. J Lab Clin Med 67(6):934-936
26. Borjigin J, Payne AS, Deng J, Li X, Wang MM, Ovodenko B, Gitlin JD, Snyder SH (1999) A novel pineal night-specific ATPase encoded by the Wilson disease gene. J Neurosci 19(3):1018-1026
27. Borjigin J, Zhang LS, Calinescu AA (2012) Circadian regulation of pineal gland rhythmicity. Mol Cell Endocrinol 349(1):13-19. doi: 10.1016/j.mce.2011.07. 009
28. Liu T, Borjigin J (2006) Relationship between nocturnal serotonin surge and melatonin onset in rodent pineal gland. J Circadian Rhythms 4:12. doi: 10.1186/1740-3391-4-12
29. Sun X, Deng J, Liu T, Borjigin J (2002) Circadian 5-HT production regulated by adrenergic signaling. Proc Natl Acad Sci USA 99(7):4686-4691. doi: 10.1073/pnas.062585499062585499
30. Huang Z, Deng J, Borjigin J (2005) A novel H28Y mutation in LEC rats leads to decreased NAT protein stability in vivo and in vitro. J Pineal Res 39(1):84-90. doi: 10.1111/j.1600-079X.2005.00222.x
31. Litwin T, Gromadzka G, Czlonkowska A, Golebiowski M, Poniatowska R (2013) The effect of gender on brain MRI pathology in Wilson's disease. Metab Brain Dis 28(1):69-75. doi: 10.1007/s11011-013-9378-2
32. Litwin T, Gromadzka G, Czlonkowska A (2012) Gender differences in Wilson's disease. J Neurol Sci 312(1-2):31-35. doi: 10.1016/j.jns.2011.08.028